AMDI Launches Autolab™ HBH at ESCMID 2025, Redefining Sample Prep for Molecular Diagnostics

"The Autolab™ HBH system was developed to overcome the longstanding challenges in sample prep—namely complexity, cost, and time," said David Okrongly, CEO of AMDI. "This launch reflects our ongoing mission to deliver advanced tools that generalize and thus improve molecular laboratory workflows and enable broader access to high-quality molecular testing, from PCR to sequencing."

Autolab™ HBH also supports sample preparation from a variety of different sample matrices, making it equally valuable in clinical research, public health, environmental monitoring, and more. It is currently available for research use only (RUO).

Live demonstrations of the Autolab™ HBH system are being held throughout the ESCMID 2025 conference at Booth #D760.

About AMDI
Autonomous Medical Devices Incorporated (AMDI) is a California-based diagnostic technology company developing next-generation solutions that improve speed, access, and accuracy in molecular testing. AMDI's products are developed and manufactured in its ISO 13485-certified facility in Santa Ana, CA.

Media Contact
Brian Miller
media@amdilabs.com 

View original content:https://www.prnewswire.co.uk/news-releases/amdi-launches-autolab-hbh-at-escmid-2025-redefining-sample-prep-for-molecular-diagnostics-302427380.html